The results showed that compared with the normal tissue, NCAPD2 promoter methylation levels decreased significantly in BLCA, BRCA, HNSCC, LIHC, LUAD, TGCT, and UCEC. The gene discussed is NCAPD2; the disease is head and neck squamous cell carcinoma.